最新ニュース Danaher (NYSE:DHR) 株価情報

Danaher

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divesititure of its environmental and applied solutions group, Veralto.

Danaher Corp

DEUTSCHE EUROSHOP UNS/ADR by Deutsche Euroshop AG

Deutsche EuroShop AG

Danaher's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) short percent of float has risen 5.83% since its last report. The company recently reported that it has 7.01 million shares sold short, which is 1.09% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.86 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Danaher Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728063924_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Danaher has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Danaher's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Danaher's peer group average for short interest as a percentage of float is 5.53%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Looking Into Danaher's Recent Short Interest

Evercore ISI Group analyst Vijay Kumar maintains Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) with a Outperform and raises the price target from $275 to $278.

News

Price Target

Analyst Ratings

Evercore ISI Group Maintains Outperform on Danaher, Raises Price Target to $278

Shares of Danaher Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) <a href="https://www.benzinga.com/quote/DHR">tanked in early trading on Tuesday</a>.
Stifel <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5def9513bffdfc0001938cfc/jacob-johnson">analyst Jacob Johnson</a> says the company is poised for a gradual recovery in 2025. It could generate high-single-digit growth in the longer term, he predicts.
The Danaher Thesis: Johnson initiated coverage of Danaher with an Overweight rating and price target of $315.
Danaher completed a spinoff of its Environmental &amp; Applied Solutions business in 2023. The company then emerged as a "pure-play LS tools company with operating companies in the Biotechnology, Life Sciences, and Diagnostics end-markets," Johnson added.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
The EAS spinoff eliminated much of Danaher's industrial exposure. As a life sciences company, it remains focused on "higher growth, recurring revenue, and margins that warrant a higher multiple," the analyst stated.
"Like the broader space, DHR has faced headwinds over the last 12 to 18 months from bioprocessing destocking, the funding environment, China, and the roll-off from COVID," he wrote, while expressing optimism around "a gradual recovery in 2025 (with a good year in bioprocessing)."
DHR Price Action: Danaher shares declined by 1.05% to $275.07 at the time of publication on Tuesday.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/40036664/jim-cramer-says-no-to-this-health-care-stock-recommends-holding-on-to-constellation-ener">Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: &#8216;It&#8217;s Up A Huge Amount&#8217;</a></li>
</ul>
Image: Shutterstock

Analyst Color

Initiation

Danaher Is Poised For 'A Good Year In Bioprocessing': Analyst

Stephens &amp; Co. analyst Jacob Johnson initiates coverage on Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) with a Overweight rating and announces Price Target of $315.

Stephens & Co. Initiates Coverage On Danaher with Overweight Rating, Announces Price Target of $315

Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) has outperformed the market over the past 10 years by 7.27% on an annualized basis producing an average annual return of 18.66%. Currently, Danaher has a market capitalization of $199.90 billion. 
Buying $1000 In DHR: If an investor had bought $1000 of DHR stock 10 years ago, it would be worth $5,524.26 today based on a price of $276.79 for DHR at the time of writing.
<h3>Danaher's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727454629_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today

Whales with a lot of money to spend have taken a noticeably bearish stance on Danaher.
Looking at options history for Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) we detected 38 trades.
If we consider the specifics of each trade, it is accurate to state that 28% of the investors opened trades with bullish expectations and 57% with bearish.
From the overall spotted trades, 12 are puts, for a total amount of $675,331 and 26, calls, for a total amount of $1,751,865.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $100.0 to $340.0 for Danaher during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Danaher options trades today is 552.21 with a total volume of 12,900.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Danaher's big money trades within a strike price range of $100.0 to $340.0 over the last 30 days.
<h3>Danaher Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727381814_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$10.5</td>
<td>$10.4</td>
<td>$10.4</td>
<td>$280.00</td>
<td>$158.0K</td>
<td>1.6K</td>
<td style="text-align: right;">579</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$10.4</td>
<td>$10.1</td>
<td>$10.4</td>
<td>$280.00</td>
<td>$144.5K</td>
<td>1.6K</td>
<td style="text-align: right;">792</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$10.6</td>
<td>$9.2</td>
<td>$10.4</td>
<td>$280.00</td>
<td>$132.0K</td>
<td>1.6K</td>
<td style="text-align: right;">993</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$19.3</td>
<td>$18.6</td>
<td>$19.3</td>
<td>$260.00</td>
<td>$115.8K</td>
<td>617</td>
<td style="text-align: right;">60</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$19.0</td>
<td>$18.6</td>
<td>$19.0</td>
<td>$260.00</td>
<td>$114.0K</td>
<td>617</td>
<td style="text-align: right;">120</td>
</tr>
</tbody>
</table>

<h3>About Danaher</h3>
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divesititure of its environmental and applied solutions group, Veralto.
<h3>Current Position of Danaher</h3>
<ul>
<li>With a trading volume of 2,617,178, the price of DHR is up by 3.38%, reaching $276.93.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 26 days from now.</li>
</ul>
<h3>What The Experts Say On Danaher</h3>
1 market experts have recently issued ratings for this stock, with a consensus target price of $300.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from RBC Capital lowers its rating to Outperform with a new price target of $300.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Danaher with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Markets

Spotlight on Danaher: Analyzing the Surge in Options Activity

Investors with a lot of money to spend have taken a bullish stance on Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with DHR, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 9 uncommon options trades for Danaher.
This isn't normal.
The overall sentiment of these big-money traders is split between 44% bullish and 44%, bearish.
Out of all of the special options we uncovered, 5 are puts, for a total amount of $239,254, and 4 are calls, for a total amount of $843,215.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $270.0 to $290.0 for Danaher during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Danaher's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Danaher's significant trades, within a strike price range of $270.0 to $290.0, over the past month.
<h3>Danaher Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727121683_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$18.3</td>
<td>$17.9</td>
<td>$18.3</td>
<td>$270.00</td>
<td>$549.0K</td>
<td>1.3K</td>
<td style="text-align: right;">305</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$5.1</td>
<td>$4.9</td>
<td>$4.9</td>
<td>$275.00</td>
<td>$169.5K</td>
<td>0</td>
<td style="text-align: right;">658</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$5.0</td>
<td>$4.9</td>
<td>$5.0</td>
<td>$275.00</td>
<td>$67.5K</td>
<td>0</td>
<td style="text-align: right;">275</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$5.0</td>
<td>$4.9</td>
<td>$5.0</td>
<td>$275.00</td>
<td>$57.1K</td>
<td>0</td>
<td style="text-align: right;">123</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$19.3</td>
<td>$18.7</td>
<td>$19.09</td>
<td>$290.00</td>
<td>$49.7K</td>
<td>89</td>
<td style="text-align: right;">26</td>
</tr>
</tbody>
</table>

<h3>About Danaher</h3>
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divesititure of its environmental and applied solutions group, Veralto.
After a thorough review of the options trading surrounding Danaher, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Danaher Standing Right Now?</h3>
<ul>
<li>With a volume of 1,107,680, the price of DHR is up 0.37% at $273.65. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 29 days.</li>
</ul>
<h3>What Analysts Are Saying About Danaher</h3>
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $290.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo has revised its rating downward to Equal-Weight, adjusting the price target to $280. 
&#x2A; An analyst from RBC Capital downgraded its action to Outperform with a price target of $300. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Danaher options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Danaher Unusual Options Activity

Financial giants have made a conspicuous bearish move on Danaher. Our analysis of options history for Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) revealed 13 unusual trades.
Delving into the details, we found 38% of traders were bullish, while 53% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $246,114, and 7 were calls, valued at $330,370.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $95.0 to $290.0 for Danaher over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Danaher's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Danaher's significant trades, within a strike price range of $95.0 to $290.0, over the past month.
<h3>Danaher 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725898546_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$182.8</td>
<td>$179.2</td>
<td>$179.2</td>
<td>$95.00</td>
<td>$89.6K</td>
<td style="text-align: right;">580</td>
<td style="text-align: right;">11</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$139.9</td>
<td>$137.0</td>
<td>$138.5</td>
<td>$135.00</td>
<td>$55.4K</td>
<td style="text-align: right;">144</td>
<td style="text-align: right;">10</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$17.9</td>
<td>$17.5</td>
<td>$17.58</td>
<td>$280.00</td>
<td>$52.7K</td>
<td style="text-align: right;">769</td>
<td style="text-align: right;">85</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$18.3</td>
<td>$17.8</td>
<td>$18.14</td>
<td>$280.00</td>
<td>$49.0K</td>
<td style="text-align: right;">769</td>
<td style="text-align: right;">55</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$17.8</td>
<td>$17.5</td>
<td>$17.51</td>
<td>$280.00</td>
<td>$43.7K</td>
<td style="text-align: right;">769</td>
<td style="text-align: right;">110</td>
</tr>
</tbody>
</table>

<h3>About Danaher</h3>
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divesititure of its environmental and applied solutions group, Veralto.
Following our analysis of the options activities associated with Danaher, we pivot to a closer look at the company's own performance.
<h3>Danaher's Current Market Status</h3>
<ul>
<li>With a trading volume of 661,435, the price of DHR is up by 1.69%, reaching $270.69.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 43 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Danaher</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $290.0.
<ul>
<li>An analyst from Wells Fargo has revised its rating downward to Equal-Weight, adjusting the price target to $280. </li>
<li>Reflecting concerns, an analyst from RBC Capital lowers its rating to Outperform with a new price target of $300.</li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Danaher, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Unpacking the Latest Options Trading Trends in Danaher

Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) has outperformed the market over the past 10 years by 7.37% on an annualized basis producing an average annual return of 17.83%. Currently, Danaher has a market capitalization of $191.18 billion. 
Buying $1000 In DHR: If an investor had bought $1000 of DHR stock 10 years ago, it would be worth $5,180.69 today based on a price of $264.71 for DHR at the time of writing.
<h3>Danaher's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725643820_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

RBC Capital analyst Conor McNamara reiterates Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) with a Outperform and maintains $300 price target.

Reiteration

RBC Capital Reiterates Outperform on Danaher, Maintains $300 Price Target

Whales with a lot of money to spend have taken a noticeably bearish stance on Danaher.
Looking at options history for Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) we detected 14 trades.
If we consider the specifics of each trade, it is accurate to state that 14% of the investors opened trades with bullish expectations and 35% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $175,791 and 11, calls, for a total amount of $314,530.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $135.0 to $270.0 for Danaher during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Danaher's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Danaher's substantial trades, within a strike price spectrum from $135.0 to $270.0 over the preceding 30 days.
<h3>Danaher 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725550332_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$3.5</td>
<td>$3.1</td>
<td>$3.1</td>
<td>$260.00</td>
<td>$93.0K</td>
<td>2.4K</td>
<td style="text-align: right;">300</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$13.9</td>
<td>$13.4</td>
<td>$13.75</td>
<td>$270.00</td>
<td>$44.3K</td>
<td>416</td>
<td style="text-align: right;">32</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$132.8</td>
<td>$130.1</td>
<td>$131.3</td>
<td>$135.00</td>
<td>$39.3K</td>
<td>82</td>
<td style="text-align: right;">42</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$132.6</td>
<td>$130.0</td>
<td>$131.2</td>
<td>$135.00</td>
<td>$39.3K</td>
<td>82</td>
<td style="text-align: right;">39</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$3.3</td>
<td>$3.0</td>
<td>$3.0</td>
<td>$250.00</td>
<td>$38.4K</td>
<td>1.7K</td>
<td style="text-align: right;">130</td>
</tr>
</tbody>
</table>

<h3>About Danaher</h3>
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divesititure of its environmental and applied solutions group, Veralto.
Having examined the options trading patterns of Danaher, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Danaher's Current Market Status</h3>
<ul>
<li>With a trading volume of 322,325, the price of DHR is down by -0.57%, reaching $262.98.</li>
<li>Current RSI values indicate that the stock is may be approaching oversold.</li>
<li>Next earnings report is scheduled for 47 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Danaher</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $280.0.
<ul>
<li>An analyst from Wells Fargo downgraded its action to Equal-Weight with a price target of $280. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Danaher options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Smart Money Is Betting Big In DHR Options

The Company provides forecasted sales only on a non-GAAP core revenue basis because of the difficulty in estimating the other components of GAAP revenue, such as currency translation, acquisitions and divested product lines.&nbsp;
For both the&nbsp;third quarter&nbsp;and full year 2024, the Company continues to expect that non-GAAP core revenue will be down low-single digits year-over-year.

Guidance

Danaher Confirms Previously Issued Guidance For Q3 And Full Year 2024 Ahead Of Previously Scheduled Analyst Event

Wells Fargo analyst Brandon Couillard initiates coverage on Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) with a Equal-Weight rating and announces Price Target of $280.

Wells Fargo Initiates Coverage On Danaher with Equal-Weight Rating, Announces Price Target of $280

Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) has outperformed the market over the past 10 years by 7.18% on an annualized basis producing an average annual return of 18.0%. Currently, Danaher has a market capitalization of $195.04 billion. 
Buying $1000 In DHR: If an investor had bought $1000 of DHR stock 10 years ago, it would be worth $5,234.55 today based on a price of $270.06 for DHR at the time of writing.
<h3>Danaher's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1724684418_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,200 Today

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Health Care sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$35.00</td>
<td>$127.1K</td>
<td>48.0K</td>
<td>3.3K</td>
</tr>
<tr>
<td>NTRA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$105.00</td>
<td>$36.6K</td>
<td>113</td>
<td>1.7K</td>
</tr>
<tr>
<td>UNH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$450.00</td>
<td>$30.7K</td>
<td>575</td>
<td>519</td>
</tr>
<tr>
<td>CVS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/20/24</td>
<td>$57.50</td>
<td>$28.0K</td>
<td>3.2K</td>
<td>322</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>08/16/24</td>
<td>$85.00</td>
<td>$29.7K</td>
<td>945</td>
<td>153</td>
</tr>
<tr>
<td>QDEL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$60.00</td>
<td>$29.0K</td>
<td>0</td>
<td>146</td>
</tr>
<tr>
<td>HROW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$12.00</td>
<td>$66.0K</td>
<td>339</td>
<td>100</td>
</tr>
<tr>
<td>BPMC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$95.00</td>
<td>$30.6K</td>
<td>1</td>
<td>80</td>
</tr>
<tr>
<td>LLY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$900.00</td>
<td>$76.0K</td>
<td>308</td>
<td>61</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$120.00</td>
<td>$75.1K</td>
<td>83</td>
<td>55</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding PFE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>), we observe a call option trade with bullish sentiment. It expires in 162 day(s) on January 17, 2025. Parties traded 3100 contract(s) at a $35.00 strike. The total cost received by the writing party (or parties) was $127.1K, with a price of $41.0 per contract. There were 48092 open contracts at this strike prior to today, and today 3303 contract(s) were bought and sold. 
• For NTRA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRA#NASDAQ">NTRA</a>), we notice a call option sweep that happens to be bearish, expiring in 8 day(s) on August 16, 2024. This event was a transfer of 39 contract(s) at a $105.00 strike. This particular call needed to be split into 10 different trades to become filled. The total cost received by the writing party (or parties) was $36.6K, with a price of $940.0 per contract. There were 113 open contracts at this strike prior to today, and today 1738 contract(s) were bought and sold. 
• For UNH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), we notice a put option sweep that happens to be bullish, expiring in 134 day(s) on December 20, 2024. This event was a transfer of 58 contract(s) at a $450.00 strike. This particular put needed to be split into 20 different trades to become filled. The total cost received by the writing party (or parties) was $30.7K, with a price of $530.0 per contract. There were 575 open contracts at this strike prior to today, and today 519 contract(s) were bought and sold. 
• Regarding CVS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>), we observe a call option trade with bearish sentiment. It expires in 43 day(s) on September 20, 2024. Parties traded 100 contract(s) at a $57.50 strike. The total cost received by the writing party (or parties) was $28.0K, with a price of $280.0 per contract. There were 3203 open contracts at this strike prior to today, and today 322 contract(s) were bought and sold. 
• Regarding MRNA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>), we observe a put option sweep with neutral sentiment. It expires in 8 day(s) on August 16, 2024. Parties traded 100 contract(s) at a $85.00 strike. This particular put needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $29.7K, with a price of $298.0 per contract. There were 945 open contracts at this strike prior to today, and today 153 contract(s) were bought and sold. 
• For QDEL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QDEL#NASDAQ">QDEL</a>), we notice a call option sweep that happens to be bullish, expiring in 225 day(s) on March 21, 2025. This event was a transfer of 121 contract(s) at a $60.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $29.0K, with a price of $240.0 per contract. There were 0 open contracts at this strike prior to today, and today 146 contract(s) were bought and sold. 
• For HROW (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HROW#NASDAQ">HROW</a>), we notice a call option trade that happens to be bearish, expiring in 71 day(s) on October 18, 2024. This event was a transfer of 30 contract(s) at a $12.00 strike. The total cost received by the writing party (or parties) was $66.0K, with a price of $2200.0 per contract. There were 339 open contracts at this strike prior to today, and today 100 contract(s) were bought and sold. 
• For BPMC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPMC#NASDAQ">BPMC</a>), we notice a call option trade that happens to be bearish, expiring in 162 day(s) on January 17, 2025. This event was a transfer of 30 contract(s) at a $95.00 strike. The total cost received by the writing party (or parties) was $30.6K, with a price of $1020.0 per contract. There were 1 open contracts at this strike prior to today, and today 80 contract(s) were bought and sold. 
• For LLY (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), we notice a call option trade that happens to be bullish, expiring in 99 day(s) on November 15, 2024. This event was a transfer of 20 contract(s) at a $900.00 strike. The total cost received by the writing party (or parties) was $76.0K, with a price of $3800.0 per contract. There were 308 open contracts at this strike prior to today, and today 61 contract(s) were bought and sold. 
• Regarding DHR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>), we observe a call option sweep with bearish sentiment. It expires in 134 day(s) on December 20, 2024. Parties traded 5 contract(s) at a $120.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $75.1K, with a price of $15020.0 per contract. There were 83 open contracts at this strike prior to today, and today 55 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BPMC

HROW

MRNA

NTRA

QDEL

10 Health Care Stocks Whale Activity In Today's Session

Financial giants have made a conspicuous bullish move on Danaher. Our analysis of options history for Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) revealed 10 unusual trades.
Delving into the details, we found 60% of traders were bullish, while 10% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $1,950,976, and 2 were calls, valued at $75,645.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $260.0 and $280.0 for Danaher, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Danaher's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Danaher's whale trades within a strike price range from $260.0 to $280.0 in the last 30 days. 
<h3>Danaher Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1722870047_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$12.4</td>
<td>$11.8</td>
<td>$11.8</td>
<td>$260.00</td>
<td>$944.0K</td>
<td style="text-align: right;">593</td>
<td style="text-align: right;">808</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$16.9</td>
<td>$13.6</td>
<td>$15.5</td>
<td>$270.00</td>
<td>$578.7K</td>
<td style="text-align: right;">705</td>
<td style="text-align: right;">373</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$17.4</td>
<td>$16.7</td>
<td>$16.7</td>
<td>$280.00</td>
<td>$93.5K</td>
<td style="text-align: right;">409</td>
<td style="text-align: right;">203</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>10/18/24</td>
<td>$17.4</td>
<td>$16.8</td>
<td>$17.1</td>
<td>$280.00</td>
<td>$92.7K</td>
<td style="text-align: right;">409</td>
<td style="text-align: right;">147</td>
</tr>
<tr>
<td>DHR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>10/18/24</td>
<td>$17.4</td>
<td>$16.6</td>
<td>$16.6</td>
<td>$280.00</td>
<td>$91.3K</td>
<td style="text-align: right;">409</td>
<td style="text-align: right;">37</td>
</tr>
</tbody>
</table>

<h3>About Danaher</h3>
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divesititure of its environmental and applied solutions group, Veralto.
In light of the recent options history for Danaher, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Danaher</h3>
<ul>
<li>With a volume of 810,223, the price of DHR is down -3.07% at $268.26. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 78 days.</li>
</ul>
<h3>What Analysts Are Saying About Danaher</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $280.0.
<ul>
<li>An analyst from TD Cowen has decided to maintain their Buy rating on Danaher, which currently sits at a price target of $310. </li>
<li>An analyst from Leerink Partners has decided to maintain their Outperform rating on Danaher, which currently sits at a price target of $280. </li>
<li>Maintaining their stance, an analyst from B of A Securities continues to hold a Neutral rating for Danaher, targeting a price of $275. </li>
<li>An analyst from Barclays has decided to maintain their Equal-Weight rating on Danaher, which currently sits at a price target of $285. </li>
<li>Maintaining their stance, an analyst from Stifel continues to hold a Hold rating for Danaher, targeting a price of $250. </li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Danaher with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Behind the Scenes of Danaher's Latest Options Trends

Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) has outperformed the market over the past 10 years by 7.93% on an annualized basis producing an average annual return of 18.74%. Currently, Danaher has a market capitalization of $199.87 billion. 
Buying $1000 In DHR: If an investor had bought $1000 of DHR stock 10 years ago, it would be worth $5,561.60 today based on a price of $276.75 for DHR at the time of writing.
<h3>Danaher's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1722634229_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Danaher's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) short percent of float has fallen 21.54% since its last report. The company recently reported that it has 6.55 million shares sold short, which is 1.02% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.2 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Danaher Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1722535221_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Danaher has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Danaher's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Danaher's peer group average for short interest as a percentage of float is 5.74%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(DHR) - Analyzing Danaher's Short Interest

On CNBC's &#8220;<a href="https://www.benzinga.com/topic/mad-money-lightning-round">Mad Money Lightning Round</a>,&#8221; Jim Cramer said no to Illumina, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>), adding that he likes Danaher Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>).
Illumina will issue results for the second quarter after the <a href="https://www.benzinga.com/quote/ILMN/earnings">closing bell on Tuesday, Aug. 6</a>.
The &#8220;Mad Money&#8221; host recommended buying some Bank of America Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) stock &#8220;right here,&#8221; and buy some &#8220;in case the stock breaks 40.&#8221;
&#8220;I think this company is selling very inexpensively, and it's a good one,&#8221; he added.
On July 24, the bank's board authorized a $25 billion stock repurchase program starting Aug. 1, replacing the existing program set to expire on that date. It also raised the quarterly cash dividend to 26 cents per share, up 2 cents from the previous quarter.
Cramer said Constellation Energy Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) is a &#8220;solar play that is a very good company. It's up a huge amount versus a lot of other stocks.&#8221; He recommends buying some, holding on to it, and not selling it.
On June 24, <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/602e68e6d522ea000117865e/david-arcaro">Morgan Stanley analyst David Arcaro</a> maintained Constellation Energy with an Overweight rating and boosted the price target from $237 to $241.
When asked about Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), he said, &#8220;I think the problem with Meta right now is it's gone up so much that people are selling Meta to buy a lot of stuff in the small, medium-sized range.&#8221;
On July 26, <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/580607ae846faa000106ab43/laura-martin">Needham analyst Laura Martin</a> reiterated Meta Platforms with an Underperform rating.
ICICI Bank Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBN#NYSE">IBN</a>) is a great way to get exposure to India, Cramer said.
When asked about Organon &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OGN#NYSE">OGN</a>), he said, &#8220;Pfizer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>), Organon. These are companies that are just kind of quietly going higher. And I have to admit, that one's probably not done.&#8221;
Organon will release its second-quarter financial results before the opening bell on Aug. 6.
Price Action:
<ul>
<li>Illumina shares rose 0.9% to settle at $121.56 on Monday.</li>
<li>Bank of America shares fell 1.4% to settle at $41.09.</li>
<li>Constellation Energy fell 1.4% to close at $172.68 during Monday's session.</li>
<li>Meta shares settled at $465.71 on Monday.</li>
<li>ICICI Bank shares gained 0.1% to settle at $28.78 on Monday.</li>
<li>Organon shares gained 1.3% to close at $22.48 on Monday. </li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/40009802/top-5-financials-stocks-that-may-fall-off-a-cliff-this-month">Top 5 Financials Stocks That May Fall Off A Cliff This Month</a></li>
</ul>

Long Ideas

Media

ILMN

Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount'

These eleven large-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>QXO, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NASDAQ">QXO</a>) shares escalated 33.37% after the company announced <a href="https://www.benzinga.com//node/39880836" target="_blank" rel="noreferrer noopener">a private placement financing</a>.</li>
<li>Avantor Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVTR#NYSE">AVTR</a>) stock gained 21.62% in the last week after it was announced the stock will join the S&amp;P MidCap 400. Also, it reported better-than-expected Q2 earnings.</li>
<li>Universal Health Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) stock jumped 17.73% after the company reported better-than-expected&nbsp;Q2&nbsp;earnings and <a href="https://www.benzinga.com//node/39942622" target="_blank" rel="noreferrer noopener">increased FY 2024&nbsp;guidance</a>.</li>
<li>Manhattan Associates Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) stock upped 17.02% after reporting better-than-expected Q2 financial results. Several analysts raised their <a href="https://www.benzinga.com/quote/MANH/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecasts on the stock</a>.</li>
<li>Molina Healthcare Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) shares increased 15.53% following <a href="https://www.benzinga.com//node/39942485" target="_blank" rel="noreferrer noopener">better-than-expected&nbsp;Q2&nbsp;earnings</a>.</li>
<li>First Citizens BancShares, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NASDAQ">FCNCA</a>) shares increased 15.15% after the company reported better-than-expected earnings.</li>
<li>Tenet Healthcare Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) stock increased 13.02% after the company reported better-than-expected&nbsp;Q2&nbsp;financial results, and the company raised its FY24&nbsp;guidance&nbsp;above estimates and issued&nbsp;Q3&nbsp;guidance&nbsp;above estimates. Also, the company announced it a<a href="https://www.benzinga.com//node/39934114" target="_blank" rel="noreferrer noopener">uthorized a&nbsp;$1.5 billion&nbsp;share buyback</a>.</li>
<li>CBRE Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBRE#NYSE">CBRE</a>) shares gained 12.99% in the last week after the company raised its 2024 guidance. Several analysts raised their <a href="https://www.benzinga.com/quote/MANH/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecasts on </a><a href="https://www.benzinga.com/quote/CBRE/analyst-ratings" target="_blank" rel="noreferrer noopener">t</a><a href="https://www.benzinga.com/quote/MANH/analyst-ratings" target="_blank" rel="noreferrer noopener">he stock</a>.</li>
<li>Thermo Fisher Scientific Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>) stock rose 12.63% in the last week. The company raised <a href="https://www.benzinga.com//node/39930516" target="_blank" rel="noreferrer noopener">its annual outlook</a>.</li>
<li>Danaher Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) stock gained 11.30% are trading higher after the company reported better-than-expected Q2 earnings.</li>
<li>Lockheed Martin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) stock grew 10.72% on positive analyst <a href="https://www.benzinga.com//node/39941283" target="_blank" rel="noreferrer noopener">ratings and strong Q2 results</a>.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/07/40001668/ford-stellantis-and-dell-are-among-top-12-large-cap-losers-last-week-july-21-july-27-are-the-other">Ford, Stellantis And Dell Are Among Top 12 Large Cap Losers Last Week (July 21-July 27): Are The Others In Your Portfolio?</a></li>
</ul>
Photo via Shutterstock

Movers

AVTR

CBRE

ENPH

FCNCA

LPLA

MANH

SIRI

SPOT

Universal Health Services & Lockheed Martin Were Among Top 11 Large Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?

Tracking William Nygren's Harris Associates Portfolio - Q2 2024 Update

Dividend Champion, Contender, And Challenger Highlights: Week Of September 22

The Ultimate 5: My Highest-Conviction Dividend Stocks

Danaher Q3 Preview: Market Share Gains In Molecular Testing

RBC Capital analyst Conor McNamara maintained a Buy rating on Danaher (DHR – Research Report) on September 22 and set a price target of $333.00. Th...

RBC Capital Sticks to Its Buy Rating for Danaher (DHR)

Telesis Bio partners with Danaher company Beckman Coulter

ATS Corporation: Diamond In The Rough

Shelton Sustainable Equity Fund Q2 2024 Commentary

3 Dividend Titans With Pricing Power Straight From The Hedge Fund Playbook

Wells Fargo's 'Core' stocks: GOOGL, HD, KO, and more

AAPL

ABBNY

ABLZF

ALLE

ALLY

AMCR

AMZN

AUBN

AVGO

BANF

BEPC

BSVN

CHTR

CMCSA

COFS

CSCO

CSGS

CSWC

CTRE

CZFS

EFSC

ENSG

EPRT

FBNC

FCPT

FFMR

FITB

FMNB

FSFG

GAIN

GATX

GILD

GNTY

GOOG

GOOGL

GSBC

GWRS

HEES

HLAN

HOFT

IIPR

INVH

IROQ

ISTR

JKHY

KFRC

KVUE

LANC

LAND

LBTYK

LDOS

LECO

LOGI

LSTR

MDLZ

MPWR

MSFT

NDAQ

NVST

NXRT

OCSL

OFLX

OLED

OMRNF

OMRNY

ORCL

OTEX

PAYX

PINE

PLOW

PNBI

POWI

QCOM

QNBC

REXR

SBUX

SCHW

SEMHF

SMMNY

STAG

STLD

TBIO

TFII

TOWN

TRNO

TROW

VCTR

VRSK

XRAY

YORW

Press Releases

Beckman Coulter Introduces New Integrated Chemistry and Immunoassay Analyzer

Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening

Danaher Releases 2024 Sustainability Report

Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development

Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration

Danaher to Webcast Diagnostics Investor & Analyst Meeting in Washington, D.C.

Danaher Confirms Third Quarter and Full Year 2024 Guidance

Dividends

Danaher Announces Quarterly Dividend

Beckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership

Danaher Schedules Third Quarter 2024 Earnings Conference Call

Agilent Technologies

Avantor

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. Class B Common Stock

BioLife Solns

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Evotec

Fortrea Holdings

Comments

Danaher

ニュース

最新ニュース Danaher (NYSE:DHR) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル